financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Lifts Opinion On Shares Of General Mills, Inc. To Hold From Sell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Lifts Opinion On Shares Of General Mills, Inc. To Hold From Sell
Mar 20, 2024 8:55 AM

11:15 AM EDT, 03/20/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lift our 12-month target to $76 from $60, 16x our FY 25 EPS view of $4.76 (up from $4.60; FY 24's up to $4.70 from $4.56) vs. the 17x long-term mean. FQ3 (Feb-Q) adj-EPS of $1.17 (+21% Y/Y) beat by $0.12. Organic sales fell 1% Y/Y, but volumes improved sequentially from FQ2 (-2% vs. -4%). Pricing moderated to +2% vs. +3% in FQ2. The highlight was the sequential improvement in Pet, which saw volumes of -5% Y/Y vs. -11% Y/Y in FQ2. North America Retail volumes also improved sequentially (-2% vs. -5%). Volumes should inflect positive in a few quarters, as GIS is beginning to lap two major headwinds from last year: 1) SNAP reduction from March '23, and 2) competitors improving their on-shelf availability. Cost savings continue to be strong and above pre-pandemic rates, which we think will continue in FY 25. That said, incentive-based comp will likely come back in FY 25 and limit EPS growth. While sales and margins are moving in the right direction, we still believe FY 25 will be a below-algorithm type of year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Buy Opinion On Shares Of Boston Scientific Corporation
Research Alert: CFRA Keeps Buy Opinion On Shares Of Boston Scientific Corporation
Mar 11, 2024
01:05 PM EDT, 03/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target price on shares of Boston Scientific ( BSX ) to $75 from $71, 29.3x our 2025 EPS estimate, a premium to BSX's historical forward average, justified...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Consolidated Communications Holdings
Research Alert: CFRA Maintains Hold Opinion On Shares Of Consolidated Communications Holdings
Mar 11, 2024
12:10 PM EDT, 03/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $5, applying an EV/sales multiple of 2.8x to our 2024 estimate, in line with its 10-year historical average multiple at 2.8x, reflecting our...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Docusign, Inc.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Docusign, Inc.
Mar 11, 2024
10:45 AM EDT, 03/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $5 to $65, applying an EV/sales multiple of 4.2x to our FY 2025 (Jan.) estimate, a slight premium to peers, reflecting its dominant...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Ciena Corporation
Research Alert: CFRA Maintains Hold Opinion On Shares Of Ciena Corporation
Mar 11, 2024
10:50 AM EDT, 03/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $5 to $55, 24.0x our FY 2024 (Oct.) EPS estimate, a discount to its three-year historical average P/E multiple of 28.1x, reflecting our...
Copyright 2023-2026 - www.financetom.com All Rights Reserved